ORBIMED ADVISORS LLC – Travere Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$30.87M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+1.69%
quarter
Travere Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +62.28% | 480.93K shares | 12.16M | $24.64 | 1.25M |
| Q2 2022 | share | Increase | 0.00% | 772.2K shares | 18.71M | $24.23 | 772.2K |
| Q2 2021 | share | Decrease | -100.00% | -528.1K shares | -13.18M | $14.59 | 0 |
| Q1 2021 | share | Increase | 0.00% | 528.1K shares | 13.18M | $24.97 | 528.1K |